Healthcare & Life Sciences
Onconick First
Poland
About
The company conducts research and development activities aimed at assessing the effectiveness and safety of antibody-drug conjugates (ADCs), an advanced method for treating cancer.
Explore Onconick First's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.